Staphylococcal Infections

2021 ◽  
pp. 25-26
Molecules ◽  
2021 ◽  
Vol 26 (6) ◽  
pp. 1758
Author(s):  
Urszula Wójcik-Bojek ◽  
Joanna Rywaniak ◽  
Przemysław Bernat ◽  
Anna Podsędek ◽  
Dominika Kajszczak ◽  
...  

Staphylococcus aureus is still one of the leading causes of both hospital- and community-acquired infections. Due to the very high percentage of drug-resistant strains, the participation of drug-tolerant biofilms in pathological changes, and thus the limited number of effective antibiotics, there is an urgent need to search for alternative methods of prevention or treatment for S. aureus infections. In the present study, biochemically characterized (HPLC/UPLC–QTOF–MS) acetonic, ethanolic, and water extracts from fruits and bark of Viburnum opulus L. were tested in vitro as diet additives that potentially prevent staphylococcal infections. The impacts of V. opulus extracts on sortase A (SrtA) activity (Fluorimetric Assay), staphylococcal protein A (SpA) expression (FITC-labelled specific antibodies), the lipid composition of bacterial cell membranes (LC-MS/MS, GC/MS), and biofilm formation (LIVE/DEAD BacLight) were assessed. The cytotoxicity of V. opulus extracts to the human fibroblast line HFF-1 was also tested (MTT reduction). V. opulus extracts strongly inhibited SrtA activity and SpA expression, caused modifications of S. aureus cell membrane, limited biofilm formation by staphylococci, and were non-cytotoxic. Therefore, they have pro-health potential. Nevertheless, their usefulness as diet supplements that are beneficial for the prevention of staphylococcal infections should be confirmed in animal models in the future.


2020 ◽  
Vol 474 (1-2) ◽  
pp. 57-72
Author(s):  
Sulagna Dutta ◽  
Pallav Sengupta ◽  
Emmanuel Izuka ◽  
Ifeanyi Menuba ◽  
Ravindran Jegasothy ◽  
...  

2000 ◽  
Vol 21 (11) ◽  
pp. 745-749 ◽  
Author(s):  
Virginia R. Roth ◽  
Cathryn Murphy ◽  
Trish M. Perl ◽  
Alfred DeMaria ◽  
Annette H. Sohn ◽  
...  

AbstractRoutine use of mupirocin to prevent staphylococcal infections is controversial. We assessed attitudes and practices of healthcare professionals attending the Fourth Decennial International Conference on Nosocomial and Healthcare-Associated Infections regarding mupirocin prophylaxis. Eighty percent of participants did not use mupirocin routinely. At the end of the session, 58% indicated they would consider increased use of mupirocin.


BMJ ◽  
1966 ◽  
Vol 1 (5483) ◽  
pp. 319-322 ◽  
Author(s):  
E. A. Mortimer ◽  
E. Wolinsky ◽  
A. J. Gonzaga ◽  
C. H. Rammelkamp

Sign in / Sign up

Export Citation Format

Share Document